[HTML][HTML] Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease
K Hufnagel, A Fathi, N Stroh, M Klein… - Communications …, 2023 - nature.com
Background The clinical course of COVID-19 patients ranges from asymptomatic infection,
via mild and moderate illness, to severe disease and even fatal outcome. Biomarkers which …
via mild and moderate illness, to severe disease and even fatal outcome. Biomarkers which …
[PDF][PDF] Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease
K Hufnagel, A Fathi, N Stroh, M Klein, F Skwirblies… - scienceopen.com
Background The clinical course of COVID-19 patients ranges from asymptomatic infection,
via mild and moderate illness, to severe disease and even fatal outcome. Biomarkers which …
via mild and moderate illness, to severe disease and even fatal outcome. Biomarkers which …
Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease.
K Hufnagel, A Fathi, N Stroh, M Klein… - Communications …, 2023 - europepmc.org
Background The clinical course of COVID-19 patients ranges from asymptomatic infection,
via mild and moderate illness, to severe disease and even fatal outcome. Biomarkers which …
via mild and moderate illness, to severe disease and even fatal outcome. Biomarkers which …
Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease
K Hufnagel, A Fathi, N Stroh, M Klein… - Communications …, 2023 - pubmed.ncbi.nlm.nih.gov
Background The clinical course of COVID-19 patients ranges from asymptomatic infection,
via mild and moderate illness, to severe disease and even fatal outcome. Biomarkers which …
via mild and moderate illness, to severe disease and even fatal outcome. Biomarkers which …
Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease
K Hufnagel, A Fathi, N Stroh, M Klein… - Communications …, 2023 - search.proquest.com
Background The clinical course of COVID-19 patients ranges from asymptomatic infection,
via mild and moderate illness, to severe disease and even fatal outcome. Biomarkers which …
via mild and moderate illness, to severe disease and even fatal outcome. Biomarkers which …
[HTML][HTML] Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease
K Hufnagel, A Fathi, N Stroh, M Klein… - Communications …, 2023 - ncbi.nlm.nih.gov
Background The clinical course of COVID-19 patients ranges from asymptomatic infection,
via mild and moderate illness, to severe disease and even fatal outcome. Biomarkers which …
via mild and moderate illness, to severe disease and even fatal outcome. Biomarkers which …
Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease.
K Hufnagel, A Fathi, N Stroh, M Klein… - Communications …, 2023 - europepmc.org
Background The clinical course of COVID-19 patients ranges from asymptomatic infection,
via mild and moderate illness, to severe disease and even fatal outcome. Biomarkers which …
via mild and moderate illness, to severe disease and even fatal outcome. Biomarkers which …